(Q36414920)

14 August 2017

1 reference

title

Role of vitamins, minerals and supplements in the prevention and management of prostate cancer (English)

1 reference

14 August 2017

1 reference

2

Franklin C Lowe

1 reference

14 August 2017

Vincent M Santillo

1

1 reference

14 August 2017

publication date

1 January 2006

1 reference

International Brazilian Journal of Urology

14 August 2017

published in

1 reference

14 August 2017

volume

32

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

3-14

1 reference

Men with prostate cancer: making decisions about complementary/alternative medicine

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Herbal and vitamin supplement use in a prostate cancer screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Vitamin E and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

The role of prostaglandin synthesis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Update on chemoprevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Excessive oral zinc supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Selenium, zinc, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

The role of soy phytoestrogens in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

The specific role of isoflavones in reducing prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Tomato products, lycopene, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Intake of carotenoids and retinol in relation to risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Re: Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Effects of lycopene supplementation in patients with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Phase I trial of oral green tea extract in adult patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Black tea consumption and cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Protective effect of green tea against prostate cancer: A case‐control study in southeast China

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Green tea and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Nutritional fats and the risk of type 2 diabetes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

21 January 2018

PC-SPES: hope or hype?

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

PC-SPES: herbal formulation for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Fatty fish consumption and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Chemoprevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Zinc supplement use and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

The role of soy phytoestrogens in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Alcohol and other beverage use and prostate cancer risk among Canadian men

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Prospective study of plasma fatty acids and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Association of energy and fat intake with prostate carcinoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

Obesity and the risk of prostate cancer (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000100002

10.1590/S1677-55382006000100002

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference